Associate Professor, Hematology and Oncology, Baylor College of Medicine

Internal Medicine

Martha Mims works in the field of Internal Medicine. She went to Baylor College of Medicine. Martha P. Mims, MD is also a published physician. She has 33 publication published. The most recent publication is: A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. She is registered with Medicare and accepts Medicare payments.

Publications

---

• Complementation of Antigen-presenting Cells to Generate T Lymphocytes With Broad Target Specificity.
• SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory Acute lymphocytic leukaemia.
• Treatment of refractory thrombotic thrombocytopenic purpura With N-acetylcysteine: a case report.
• HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate Cancer.
• Combining T-cell immunotherapy and anti-androgen therapy for prostate Cancer.
• GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate Cancer preceding r...
• Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic Leukemia.
• CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T Cells in lymphoma patients.
• Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt.
• Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.
• DMT1 mutation: response of Anemia to darbepoetin administration and implications for iron homeostasis.
• Identification of a human mutation of DMT1 in a patient with microcytic Anemia and iron overload.
• Progressive transfusion and growth factor independence With adjuvant sertraline in low risk myelodysplastic syndrome treated With an erythropoiesis stimulating agent a...
• Effect of Immune reconstitution on the incidence of HIV-related Hodgkin lymphoma.
• Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid Leukemia.
• Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem Cell transplantation.
• Iron-overload in long-term survivors of hematopoietic transplantation.
• Analysis of the E399D mutation in SLC11A2.
• High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor Cells.
• Acute cardiorespiratory collapse from heparin: a consequence of heparin-induced thrombocytopenia.
• A novel DNA-peptide complex for efficient gene transfer and expression in mammalian Cells.
• Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein recept...
• Interaction of LDL and Lp[a] With human skin fibroblasts.
• Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine. Apolipoprotein B, lipoprotein[a], and transplantation arteriopathy.
• Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E.
• A nonexchangeable apolipoprotein E peptide that mediates binding to the low density lipoprotein receptor.
• In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic deLivery of the rabbit LDL receptor gene.
• Murine VCAM-1. Molecular cloning, mapping, and Analysis of a truncated form.
• Divalent metal transporter 1.
• Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory Acute lymphocytic leukaemia.
• Genomic profiling of prostate Cancers from African American men.
• Neoadjuvant chemotherapy preceding cystectomy for bladder Cancer.

Schools

---

• Baylor University

• Baylor College Of Med

Conditions Treated

---

• Acute Leukemia
• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology
• Internal Medicine

Accepted Insurances

---

Education

---

• Baylor College of Medicine

Hospital

---

• Baylor St. Luke's Medical Center

Drug Facts

---

NPI NUMBER		1295954147
NPPES Provider LastName		MIMS
NPPES Provider FirstName		MARTHA
NPPES Provider ZIPCode		770301608
NPPES Provider State		TX
Specialty Description		Hematology/Oncology
Total Claim Count		221.0
Distinct Opioid Count		1.0
Opioid Claim Count		31.0
Percent Opioid Claims		14.03

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1295954147
Last Name Of The Provider	MIMS
First Name Of The Provider	MARTHA
View All

Similar Doctors

---

	Dr. William C. Pugh, MD This Doctor is OpenDoctor Recommended.
	Dr. David A. Sears, MD
	Dr. Dong S. Kim, MD
	Dr. Oyebola O. Oladiran, MD This Doctor is OpenDoctor Recommended.
	Dr. Craig A. Kovitz, MD This Doctor is OpenDoctor Recommended.
	Dr. Hagop M. Kantarjian, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Kimberly H. Koenig, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael J. Overman, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Vivek Subbiah, MD This Doctor is OpenDoctor Recommended.
	Dr. Gabriel N. Hortobagyi, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Mary V. Gresik, MD This Doctor is OpenDoctor Recommended.
	Dr. Effrosyni Apostolidou, MD
	Dr. Loretta J. Nastoupil, MD This Doctor is OpenDoctor Recommended.
	Dr. Chad Pecot, MD This Doctor is OpenDoctor Recommended.
	Dr. Mingjian J. You, MD This Doctor is OpenDoctor Recommended.
	Dr. Shi-Ming Tu, MD
	Dr. Nuhad K. Ibrahim, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jesus H. Hermosillo, MD
	Dr. An N. Hoang, MD
	Dr. Nickalaus L. Gramze, MD This Doctor is OpenDoctor Recommended.
	Dr. Winston E. Watkins Jr., MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog